Mandatory notification of transaction

31 August 2026

Reference is made to the stock exchange announcements published by Nykode Therapeutics ASA (the "Company") regarding the successful placing of a private placement and allocation to companies closely associated with primary insiders of the Company, including Rasmussengruppen AS. Rasmussengruppen AS has today made certain intra-group transfers of certain of the shares allocated in the private placement to Portia AS and Cressida AS as further described in the attached forms.

Disclosure regulation This information is subject to the disclosure requirements in articles 19 of the Regulation EU 596/2014 (the EU Market Abuse Regulation) and section 5-12 of the Norwegian Securities Trading Act.